Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin

NCT03066830 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

507

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sotagliflozin (SAR439954)
DRUG: Placebo
DRUG: Metformin
DRUG: Sulfonylurea

Sponsor

Lexicon Pharmaceuticals

Collaborators

[object Object]